Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.19.3
Condensed Balance Sheets - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current Assets    
Cash $ 2,455,323 $ 5,459,884
Accounts receivable, net 1,674,896 985,854
Factor receivables, net 944,964 1,542,835
Inventory 1,774,439 379,915
Prepaid assets 214,514 222,000
Total Current Assets 7,064,136 8,590,488
Other Assets    
Property and equipment, net 718,339 224,196
Note receivable 4,780,000
Other assets 102,429 36,014
Total Assets 12,664,904 8,850,698
Current Liabilities    
Accounts payable 2,045,019 1,962,901
Accrued expenses 385,735 927,569
Deferred revenue 107,776
Factor loan payable 680,668 1,304,512
Warrant derivative 482,489 23,507,247
Convertible notes payable - current 3,625,556
Total Current Liabilities 7,219,467 27,810,005
Convertible notes payable - net of current portion 5,273,357
Total Liabilities 12,492,824 27,810,005
Shareholders' Equity (Deficit)    
Series C Preferred Stock, $.0001 par value, 3,268 and 0 shares authorized, issued, and outstanding at September 30, 2019 and December 31, 2018, respectively. No liquidation preference.
Common stock, $0.0001 par value, 100,000,000 shares authorized, 27,804,254 and 9,870,873 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively 2,800 987
Additional paid-in capital 41,463,387 20,152,107
Accumulated deficit (41,294,108) (39,112,401)
Total Shareholders' Equity (Deficit) 172,079 (18,959,307)
Total Liabilities and Shareholders' Equity (Deficit) $ 12,664,903 $ 8,850,698